Jiangsu Province Centers for Disease Control and Prevention
Quick facts
Marketed products
- 23vPPV+TIV · Immunology / Infectious Disease
A combined pneumococcal and influenza vaccine that stimulates immune responses against 23 serotypes of Streptococcus pneumoniae and seasonal influenza virus strains. - A+C Vaccine · Immunology / Infectious Disease
A+C Vaccine is a combined meningococcal vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroups A and C. - Ad5-nCoV-IH
- Ad5-nCoV-IM
- Aerosolized Ad5-nCoV
- Attenuated Hepatitis A Vaccine, H2 Strain · Immunology
The Attenuated Hepatitis A Vaccine, H2 Strain, works by introducing a live, weakened form of the hepatitis A virus to stimulate an immune response. - batch 1 of Ad5-nCoV · Immunology / Infectious Disease
Ad5-nCoV is a recombinant adenovirus type 5 vector vaccine that delivers the SARS-CoV-2 spike protein gene to stimulate immune responses against COVID-19. - batch 2 of Ad5-nCoV
- batch 3 of Ad5-nCoV · Immunology / Infectious Disease
Ad5-nCoV is a recombinant adenovirus type 5 vector vaccine that delivers the SARS-CoV-2 spike protein gene to stimulate immune responses against COVID-19. - Double dosage inactivated vaccine
- Intramuscularly administered Ad5-nCoV vaccine · Immunology / Infectious Disease
An adenovirus type 5 (Ad5) vector vaccine delivers the SARS-CoV-2 spike protein gene intramuscularly to stimulate cellular and humoral immune responses against COVID-19. - Intranasal Influenza Live Attenuated Vaccine · Immunology
This live attenuated influenza vaccine stimulates immune responses by delivering weakened influenza virus strains intranasally to induce mucosal and systemic immunity. - Recombinant SARS-CoV-2 Ad5 vectored vaccine
- Standard dosage inactivated vaccine
- SYS6006 · Oncology
Phase 3 pipeline
- A+C+hib Conjugate Vaccine · Immunology / Infectious Disease
A conjugate vaccine that combines antigens from meningococcus serogroups A and C with Haemophilus influenzae type b (Hib) to stimulate immune responses against these bacterial pathogens. - Active Comparator hepatitis B vaccine · Immunology
A hepatitis B vaccine that stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen. - Changchun Werersai
Changchun Werersai's mechanism of action is currently unknown. - DTaP Vaccine A · Immunology
DTaP vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria toxin, tetanus toxin, and pertussis antigens. - DTaP Vaccine B · Immunology
DTaP Vaccine B stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, and pertussis pathogens. - Experimental recombinant hepatitis B vaccine · Immunology
This recombinant hepatitis B vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen, providing protection against hepatitis B infection. - H. pylori vaccine · Infectious Disease
This vaccine stimulates the immune system to recognize and eliminate Helicobacter pylori bacteria, preventing infection and associated gastric diseases. - Inactivated SARS-CoV-2 vaccine · Immunology / Infectious Disease
This inactivated vaccine trains the immune system to recognize and neutralize SARS-CoV-2 by presenting killed viral particles that cannot cause infection. - Jilin Maifeng · Immunology
Jilin Maifeng is a traditional Chinese medicine formulation designed to support immune function and respiratory health. - Placebo Comparator: Placebo control
Placebo is an inert substance with no active pharmacological mechanism; it serves as a control comparator in clinical trials. - Positive control vaccine 1 · Immunology
A positive control vaccine designed to elicit immune responses by presenting antigenic material to stimulate adaptive immunity. - Positive control vaccine 2 · Immunology
A positive control vaccine designed to elicit immune responses as a reference standard in clinical trials.
Phase 2 pipeline
- Influenza virus split vaccine · Infectious Disease
Influenza virus split vaccines contain inactivated influenza viruses that have been disrupted to release viral antigens, which stimulate an immune response against the influenza virus. - Three-dose regimen of commercialized IPV
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Jiangsu Province Centers for Disease Control and Prevention portfolio CI brief
- Jiangsu Province Centers for Disease Control and Prevention pipeline updates RSS
Frequently asked questions about Jiangsu Province Centers for Disease Control and Prevention
What are Jiangsu Province Centers for Disease Control and Prevention's marketed drugs?
Top marketed products include 23vPPV+TIV, A+C Vaccine, Ad5-nCoV-IH, Ad5-nCoV-IM, Aerosolized Ad5-nCoV, Attenuated Hepatitis A Vaccine, H2 Strain.
What is Jiangsu Province Centers for Disease Control and Prevention's pipeline?
Jiangsu Province Centers for Disease Control and Prevention has 12 drugs in Phase 3, 2 in Phase 2, 3 in Phase 1. Late-stage candidates include A+C+hib Conjugate Vaccine, Active Comparator hepatitis B vaccine, Changchun Werersai, DTaP Vaccine A.
Related
- 23vPPV+TIV · Immunology / Infectious Disease
- A+C Vaccine · Immunology / Infectious Disease
- Ad5-nCoV-IH
- Ad5-nCoV-IM
- Aerosolized Ad5-nCoV
- Sector hub: All tracked pharma companies